Holen Sie sich die Stockscreener-App
29.49
0.27%
-0.08
Vorhandelsmarkt:
29.62
0.13
+0.44%
Schlusskurs vom Vortag:
$29.57
Offen:
$29.38
24-Stunden-Volumen:
1.52M
Relative Volume:
1.10
Marktkapitalisierung:
$2.32B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-39.32
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
-3.88%
1M Leistung:
+25.44%
6M Leistung:
-28.16%
1J Leistung:
-6.94%
1-Tages-Spanne:
$28.89
$29.68
1-Wochen-Bereich:
$28.89
$30.63
52-Wochen-Spanne:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
29.49 | 2.37B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
494.81 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.40 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.85 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.11 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
192.04 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte's Turnaround Potential: Navigating Financial Struggles and Strategic Realignments Amidst a Competitive Landscape - AInvest
Veracyte Inc. Recovery Linked to Earnings SurpriseJuly 2025 Retail & Pattern Based Trade Signal System - newsimpact.co.kr
Veracyte Inc. Breaks Losing Streak — Is the Trend Reversing2025 AllTime Highs & Fast Exit and Entry Trade Guides - classian.co.kr
Sentiment Tools Show Shift in Trader Mood on Veracyte Inc.Portfolio Profit Report & Smart Money Movement Tracker - newsimpact.co.kr
Veracyte Inc. Builds Base for Possible ReboundPortfolio Return Report & Risk Adjusted Buy/Sell Alerts - thegnnews.com
Trapped Investors in Veracyte Inc. Await Breakout SignalWeekly Loss Report & Short-Term Trading Alerts - sundaytimes.kr
Volatility clustering patterns for Veracyte Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - Newser
Veracyte Inc.’s volatility index tracking explainedMarket Rally & AI Enhanced Execution Alerts - Newser
Is a relief rally coming for Veracyte Inc. holdersJuly 2025 Momentum & Technical Pattern Based Signals - Newser
Forecasting Veracyte Inc. price range with options data2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Real time alert setup for Veracyte Inc. performanceInsider Buying & Stock Portfolio Risk Control - Newser
Is now a turning point for Veracyte Inc.July 2025 Sentiment & Stock Market Timing Techniques - Newser
Why Veracyte Inc. stock attracts strong analyst attentionWeekly Loss Report & Daily Momentum Trading Reports - Newser
Here's Why Veracyte (VCYT) is a Strong Growth Stock - Yahoo Finance
Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality - Yahoo Finance
Veracyte Inc. Inches Above Key Support — Safe to HoldJuly 2025 Institutional & Free Real-Time Volume Trigger Notifications - thegnnews.com
PNC Financial Services Group Inc. Cuts Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
How Resilient Is Veracyte Inc. Stock During Economic Downturns2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Blair William & Co. IL - Defense World
VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up - Yahoo Finance
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Is Veracyte Inc. a Top Dividend Stock to Watch in 2025Price Movement and Market Sentiment Analysis - Newser
Candlestick Signal Suggests Reversal in Veracyte Inc.Chart-Based Trade Entries Gain Analyst Support - metal.it
Veracyte stock price target lowered to $28 from $29 at Morgan Stanley By Investing.com - Investing.com South Africa
Veracyte stock price target lowered to $28 from $29 at Morgan Stanley - Investing.com Australia
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns - TipRanks
Veracyte price target lowered to $28 from $29 at Morgan Stanley - TipRanks
A Quick Look at Today's Ratings for Veracyte(VCYT.US), With a Forecast Between $41 to $45 - 富途牛牛
Veracyte, Inc. (NASDAQ:VCYT) Q2 2025 Earnings Call Transcript - Insider Monkey
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones - TipRanks
Veracyte Receives Buy Rating and $37 Price Target from Guggenheim Analyst - AInvest
Veracyte’s Revenue Growth Outpaces Forecasts And Lifts Guidance - Finimize
Veracyte’s Strong Financial Performance and Promising Growth Prospects Justify Buy Rating - TipRanks
Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care - AInvest
Veracyte (VCYT) Q2 Revenue Jumps 14% - AOL.com
Veracyte stock rating reiterated at Outperform by William Blair - Investing.com India
Earnings call transcript: Veracyte’s Q2 2025 earnings beat expectations, stock falls - Investing.com Canada
Earnings call transcript: Veracyte’s Q2 2025 earnings beat expectations, stock falls By Investing.com - Investing.com South Africa
Transcript : Veracyte, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Veracyte: Q2 Earnings Snapshot - Greenwich Time
Veracyte's 2025 Q2 Financial Performance and Strategic Momentum: A Deep Dive into Diagnostic Innovation and Oncology Expansion - AInvest
Veracyte Announces Second Quarter 2025 Financial Results - BioSpace
Veracyte's 2025 Earnings Call: A Catalyst-Driven Path to Sustained Double-Digit Growth and 25%+ Adjusted EBITDA Margins - AInvest
Veracyte Reports Strong Q2 2025 Revenue Growth - TipRanks
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Veracyte Q2 2025 slides: Decipher drives 14% revenue growth, EBITDA margins expand - Investing.com Nigeria
Veracyte Q2 revenue rises 14%, beats expectations - MarketScreener
Veracyte Inc (VCYT) Q2 2025 Earnings: Revenue Surpasses Estimates at $130.2M, Reports GAAP Net Loss - GuruFocus
Veracyte shares surge as Q2 profits quadruple expectations By Investing.com - Investing.com Nigeria
Veracyte Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veracyte Inc-Aktie (VCYT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bhanji Muna | Director |
Jun 13 '25 |
Sale |
26.67 |
4,589 |
122,367 |
29,989 |
0.33%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):